This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mvrix Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Woo Jae Chung: Innovator in Viral Receptor Technology
Introduction
Woo Jae Chung is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of viral receptor technology. His innovative work focuses on enhancing the treatment of viral infections through novel compounds.
Latest Patents
Woo Jae Chung holds a patent for a viral receptor bound with sialic acid compounds. This patent, which is characterized by its unique design, provides binding affinity to viruses. The receptor contains a sialic acid compound on one side and a lipid on the other, making it a versatile tool for treating viral infections.
Career Highlights
Chung is associated with Mvrix Co., Ltd., where he continues to develop groundbreaking technologies. His work has garnered attention for its potential impact on public health and the treatment of viral diseases.
Collaborations
He collaborates with talented individuals such as Caleb Hong and Dae Hyuk Kweon, contributing to a dynamic research environment.
Conclusion
Woo Jae Chung's innovative approach to viral receptor technology positions him as a key figure in the fight against viral infections. His contributions are paving the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile